Atlantic Bone Screen

Executive Summary

Atlantic Bone Screen is a specialized preclinical research organization based in Nantes, France, offering bone histology and analysis services to support biomedical and pharmaceutical studies. Founded in 2008, the company focuses on rare disease and metabolic research, providing expertise in bone tissue analysis for drug development. As a private, pre-clinical stage company, it serves as a partner for innovation in therapeutic areas requiring bone-related endpoints. With a niche focus, Atlantic Bone Screen is positioned to benefit from increasing demand for specialized preclinical services, particularly in osteoporosis, oncology bone metastases, and rare skeletal disorders. Its service model allows flexibility and collaboration with biotech and pharma clients, though the company lacks disclosed funding or product revenue. The limited public information suggests a quiet but steady operation, with potential for growth as preclinical outsourcing trends continue.